For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260512:nRSL8468Da&default-theme=true
RNS Number : 8468D Fevertree Drinks PLC 12 May 2026
12(th) May 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 5(th) May
to 8(th) May 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
05 May 2026 XLON 808.7628 41,756 797.5000 822.0000
06 May 2026 XLON 822.7491 37,168 811.0000 830.5000
06 May 2026 AIMX 821.0000 4,317 821.0000 821.0000
07 May 2026 XLON 817.3505 19,617 811.5000 824.0000
07 May 2026 AIMX 823.5500 15,000 823.5500 823.5500
08 May 2026 XLON 811.8708 35,618 807.0000 817.0000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/8468D_1-2026-5-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/8468D_1-2026-5-11.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSXFLFFQELZBBK
Copyright 2019 Regulatory News Service, all rights reserved